You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

chemotherapy dosing

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer, Breast Carcinoma Trial in United States (Adaptive Aerobic Training/AT Dosing, Standard (fixed) Aerobic

Recruiting
  • Breast Cancer
  • Breast Carcinoma
  • Adaptive Aerobic Training/AT Dosing
  • Standard (fixed) Aerobic Training/AT dosing
  • Basking Ridge, New Jersey
  • +6 more
Jan 30, 2023

FIGO Stage III Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Carcinoma Trial in Amsterdam (Cisplatin 100 mg/m2, Cisplatin 40

Not yet recruiting
  • FIGO Stage III Ovarian Cancer
  • +2 more
  • Cisplatin 100 mg/m2
  • Cisplatin 40 mg/l
  • Amsterdam, Netherlands
    Antoni van Leeuwenhoek (NKI-AVL)
Jun 3, 2022

Breast Tumor Trial in Sao Paulo (ctDNA level during neoadjuvant chemo)

Active, not recruiting
  • Breast Neoplasm
  • ctDNA level during neoadjuvant chemotherapy
  • Sao Paulo, SP, Brazil
    IBCC Oncologia
Sep 24, 2021

Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in Canada, United States (GEN-1, Carboplatin,

Recruiting
  • Epithelial Ovarian Cancer
  • +2 more
  • GEN-1
  • +2 more
  • Birmingham, Alabama
  • +23 more
Mar 7, 2022

Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC) Trial in Pittsburgh (Pembrolizumab, Carboplatin,

Not yet recruiting
  • Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC)
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Sep 18, 2023

Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in Houston (Paclitaxel, Carboplatin, Bevacizumab)

Recruiting
  • Ovarian Cancer
  • +2 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Feb 13, 2023

Acute Myeloid Leukemia Trial in Baltimore, Houston (Atovaquone, Cytarabine, Daunorubicin)

Active, not recruiting
  • Acute Myeloid Leukemia
  • Baltimore, Maryland
  • +1 more
Oct 7, 2022

Metastatic Triple-Negative Breast Carcinoma, Breast Cancer Trial in Dallas (Neratinib Oral Tablet, Ruxolitinib Oral Tablet)

Not yet recruiting
  • Metastatic Triple-Negative Breast Carcinoma
  • Breast Cancer
  • Neratinib Oral Tablet
  • Ruxolitinib Oral Tablet
  • Dallas, Texas
    Baylor University Medical Center, Baylor Charles A Sammons Cance
Aug 22, 2023

Urothelial Carcinoma, Locally Advanced, Unresectable Trial in United States (Atezolizumab, Gemcitabine, Cisplatin)

Active, not recruiting
  • Urothelial Carcinoma
  • +2 more
  • Chicago, Illinois
  • +8 more
Dec 23, 2022

Gynecologic Malignancies Trial in Cleveland (Paclitaxel, Carboplatin)

Terminated
Has Results
  • Gynecologic Malignancies
  • Cleveland, Ohio
    Cleveland Clinic Taussig Cancer institute, Case Comprehensive Ca
Jun 29, 2022

Gastrointestinal Cancer, Breast Cancer, Head Neck Cancer Trial in Chicago (Pharmacogenomics (PGx) Testing and Genomics

Recruiting
  • Gastrointestinal Cancer
  • +4 more
  • Availability of clinical decision support based on pharmacogenomic results.
  • Chicago, Illinois
    University of Chicago Medical Center
Oct 20, 2022

Ovarian Cancer Trial in Oklahoma City (Unesbulin)

Active, not recruiting
  • Ovarian Cancer
  • Oklahoma City, Oklahoma
    University of Oklahoma Health Sciences Center
Feb 21, 2022

Metastatic Cancer Trial in Aurora (Tempol)

Available
  • Metastatic Cancer
  • Aurora, Colorado
    UCHealth University of Colorado Cancer Center - Anschutz Medical
Aug 4, 2022

Glioblastoma Trial in Worldwide (DSP-7888 Dosing Emulsion, Bevacizumab)

Active, not recruiting
  • Glioblastoma
  • Birmingham, Alabama
  • +60 more
Apr 4, 2022

NSCLC, Small Cell Lung Cancer Trial in Worldwide (Durvalumab, Cisplatin, Carboplatin)

Active, not recruiting
  • Non-Small Cell Lung Cancer
  • Small Cell Lung Cancer
  • Houston, Texas
  • +7 more
Feb 1, 2023

Extensive-stage Small-cell Lung Cancer Trial (Trilaciclib, Placebo, Topotecan)

Not yet recruiting
  • Extensive-stage Small-cell Lung Cancer
  • (no location specified)
May 22, 2023

Ovarian Cancer, Stage III Ovarian Cancer, Stage IV Ovarian Cancer Trial in Toronto (Niraparib)

Not yet recruiting
  • Ovarian Cancer
  • +3 more
  • Toronto, Ontario, Canada
    Sunnybrook Research Institute
Jul 18, 2023

Acute Lymphoblastic Leukemia, Pediatric Trial in Canada, United States (Pegaspargase, Erwinia asparaginase, Cyclophosphamide)

Active, not recruiting
  • Acute Lymphoblastic Leukemia, Pediatric
  • Boston, Massachusetts
  • +8 more
Nov 10, 2022

Recurrent Ovarian Cancer Trial in Pittsburgh (CPI-0209, carboplatin)

Not yet recruiting
  • Recurrent Ovarian Cancer
  • Pittsburgh, Pennsylvania
    Magee-Womens Research Institute / UPMC Magee Womens Hospital
Jul 3, 2023

Breast Cancer Female Trial (Vaginal Lactobacillus capsules)

Not yet recruiting
  • Breast Cancer Female
  • Vaginal Lactobacillus capsules
  • (no location specified)
Aug 2, 2023

AryoTrust® (Trastuzumab) Safety Study

Completed
  • Breast Cancer
  • Gorgān, Iran, Islamic Republic of
  • +14 more
Sep 4, 2023

Lung Cancer, NSCLC Trial (Lorlatinib, Cisplatin or Carboplatin, Pemetrexed)

Not yet recruiting
  • Lung Cancer
  • Non-small Cell Lung Cancer
  • (no location specified)
Jul 7, 2023

Small-cell Lung Cancer Trial in Guangzhou (Serplulimab)

Recruiting
  • Small-cell Lung Cancer
  • Guangzhou, Guangdong, China
    Guangdong Provincial Perople's Hospital
Jul 20, 2023

Pancreatic Ductal Adenocarcinoma, Oligometastatic Disease Trial in Baltimore (FOLFIRINOX chemo)

Not yet recruiting
  • Pancreatic Ductal Adenocarcinoma
  • Oligometastatic Disease
  • FOLFIRINOX chemotherapy
  • Baltimore, Maryland
    Johns Hopkins Hospital
Nov 2, 2023

Gastric Cancer Trial in Shanghai (sintilimab+metronomic PLOF)

Recruiting
  • Gastric Cancer
  • sintilimab+metronomic PLOF
  • Shanghai, China
    Huashan Hospital, Fudan University
Sep 22, 2023